Progranulin

Progranulin

Progranulin 분자 정보

Molecule Name
Progranulin
분자 별명
CLN11, GEP, GP88, PCDGF, PEPI, PGRN
Drug Development Progress
임상 약물 수7
시판 약물 수0
최고 연구 개발 단계Phase 2 Clinical
표적 별명
GRN
분자 배경
Progranulin, a secreted glycoprotein, is encoded in humans by the single GRN gene. Progranulin consists of seven and a half, tandemly repeated, non-identical copies of the 12 cysteine granulin motif. Many cellular processes and diseases are associated with this unique pleiotropic factor that include, but are not limited to, embryogenesis, tumorigenesis, inflammation, wound repair, neurodegeneration and lysosome function. Haploinsufficiency caused by autosomal dominant mutations within the GRN gene leads to frontotemporal lobar degeneration, a progressive neuronal atrophy that presents in patients as frontotemporal dementia.

Progranulin 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
GRN Gene Therapy(Eli Lilly And Company)PR-006; LY3884963Phase 2 ClinicalEli Lilly And Company
Frontotemporal Dementia
상세
TAK-594DNL-593; PTV:PGRN; TAK-594Phase 2 ClinicalDenali Therapeutics Inc
Frontotemporal Dementia
상세
AVB-101AVB-101Phase 2 ClinicalAviadoBio Ltd
Frontotemporal Dementia
상세
NivisnebartAL-101; GSK-4527226Phase 2 ClinicalAlector Inc
Alzheimer Disease; Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Nerve Degeneration; Parkinson Disease
상세
PBFT-02PBFT-02Phase 2 ClinicalUniversity Of Pennsylvania
Frontotemporal Dementia
상세
VGN-R13VGN-R13Phase 1 ClinicalShanghai Vitalgen BioPharma Co Ltd
Amyotrophic Lateral Sclerosis
상세
AG-01(A&G Pharm)AG-01(A&G Pharm)Phase 1 ClinicalA&G Pharmaceutical
Carcinoma, Non-Small-Cell Lung; Mesothelioma; Triple Negative Breast Neoplasms
상세